Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
David Fuchs, Alex Kilbertus, Karin Kofler, et al.
Blood Advances
|
January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
Jason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Allergy
|
February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
Johannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
The Lancet. Haematology
|
November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 21, 2020
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin
David Fuchs, Alex Kilbertus, Karin Kofler, et al.
Blood Advances
|
January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
Jason Gotlib, Andreas Reiter, Deepti H Radia, et al.
Allergy
|
February 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, et al.
The Lancet. Haematology
|
January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis
Johannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Journal of Allergy and Clinical Immunology
|
October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann, Luis Escribano, Clive Grattan, et al.
Leukemia
|
November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
The Lancet. Haematology
|
November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
Page
of 8